PortalPublikationenMedicolegal Implications of Biphasic Anaphylaxis

Medicolegal Implications of Biphasic Anaphylaxis

Standard

Medicolegal Implications of Biphasic Anaphylaxis. / Da Broi, Ugo; Moreschi, Carlo; Marega, Giulia; Tse, Rexson; Garland, Jack; Ondruschka, Benjamin; Palmiere, Cristian.

in: AM J FOREN MED PATH, Jahrgang 42, Nr. 2, 01.06.2021, S. 109-117.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Harvard

Da Broi, U, Moreschi, C, Marega, G, Tse, R, Garland, J, Ondruschka, B & Palmiere, C 2021, 'Medicolegal Implications of Biphasic Anaphylaxis', AM J FOREN MED PATH, Jg. 42, Nr. 2, S. 109-117. https://doi.org/10.1097/PAF.0000000000000621

APA

Da Broi, U., Moreschi, C., Marega, G., Tse, R., Garland, J., Ondruschka, B., & Palmiere, C. (2021). Medicolegal Implications of Biphasic Anaphylaxis. AM J FOREN MED PATH, 42(2), 109-117. https://doi.org/10.1097/PAF.0000000000000621

Vancouver

Da Broi U, Moreschi C, Marega G, Tse R, Garland J, Ondruschka B et al. Medicolegal Implications of Biphasic Anaphylaxis. AM J FOREN MED PATH. 2021 Jun 1;42(2):109-117. https://doi.org/10.1097/PAF.0000000000000621

Bibtex

@article{536cee7aabef4efe9bd941dbf719d0ca,
title = "Medicolegal Implications of Biphasic Anaphylaxis",
abstract = "ABSTRACT: Biphasic anaphylaxis is an uncommon IgE-mediated condition whose pathophysiological mechanisms, risk factors, and predictive signs are not properly understood. Fortunately, the lethality of biphasic anaphylaxis, although probably underestimated, is low. Preventive clinical measures for biphasic anaphylaxis are neither standardized nor commonly applied. Furthermore, there are no laboratory protocols or anaphylactic markers to help identify the onset of biphasic anaphylaxis in clinical settings. The aim of this review is to highlight the medicolegal difficulties facing coroners and forensic pathologists in terms of the diagnosis and assessment of harm for victims and survivors of biphasic anaphylaxis.",
author = "{Da Broi}, Ugo and Carlo Moreschi and Giulia Marega and Rexson Tse and Jack Garland and Benjamin Ondruschka and Cristian Palmiere",
year = "2021",
month = jun,
day = "1",
doi = "10.1097/PAF.0000000000000621",
language = "English",
volume = "42",
pages = "109--117",
journal = "AM J FOREN MED PATH",
issn = "0195-7910",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

RIS

TY - JOUR

T1 - Medicolegal Implications of Biphasic Anaphylaxis

AU - Da Broi, Ugo

AU - Moreschi, Carlo

AU - Marega, Giulia

AU - Tse, Rexson

AU - Garland, Jack

AU - Ondruschka, Benjamin

AU - Palmiere, Cristian

PY - 2021/6/1

Y1 - 2021/6/1

N2 - ABSTRACT: Biphasic anaphylaxis is an uncommon IgE-mediated condition whose pathophysiological mechanisms, risk factors, and predictive signs are not properly understood. Fortunately, the lethality of biphasic anaphylaxis, although probably underestimated, is low. Preventive clinical measures for biphasic anaphylaxis are neither standardized nor commonly applied. Furthermore, there are no laboratory protocols or anaphylactic markers to help identify the onset of biphasic anaphylaxis in clinical settings. The aim of this review is to highlight the medicolegal difficulties facing coroners and forensic pathologists in terms of the diagnosis and assessment of harm for victims and survivors of biphasic anaphylaxis.

AB - ABSTRACT: Biphasic anaphylaxis is an uncommon IgE-mediated condition whose pathophysiological mechanisms, risk factors, and predictive signs are not properly understood. Fortunately, the lethality of biphasic anaphylaxis, although probably underestimated, is low. Preventive clinical measures for biphasic anaphylaxis are neither standardized nor commonly applied. Furthermore, there are no laboratory protocols or anaphylactic markers to help identify the onset of biphasic anaphylaxis in clinical settings. The aim of this review is to highlight the medicolegal difficulties facing coroners and forensic pathologists in terms of the diagnosis and assessment of harm for victims and survivors of biphasic anaphylaxis.

U2 - 10.1097/PAF.0000000000000621

DO - 10.1097/PAF.0000000000000621

M3 - SCORING: Review article

C2 - 33031125

VL - 42

SP - 109

EP - 117

JO - AM J FOREN MED PATH

JF - AM J FOREN MED PATH

SN - 0195-7910

IS - 2

ER -